Xiromed LLC has recalled 40,064 units of Altavera (levonorgestrel and ethinyl estradiol) Tablets, USP 0.15 mg and 0.03 mg, a prescription oral contraceptive. The recall was initiated because the generic name was mislabeled on a packaging component, which may cause confusion for patients regarding their medication. These products were manufactured by Laboratories Leon Farma S.A. in Spain and distributed nationwide across the United States in three-dispenser packs containing 28 tablets each. Consumers should check their packaging for the specific lot numbers and expiration dates included in this recall.
The mislabeling of the generic name on the packaging can lead to patient confusion or medication errors, potentially resulting in incorrect dosing or the use of an unintended medication.
Manufacturer refund or replacement via pharmacy
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.